Dr. Joshua James Meeks , MD, PhD
Urology • Chicago, IL
675 N Saint Clair St, Galter 20-150
Chicago, IL 606115975
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 24, 2008; this date does not establish years in practice.
-
Published CMS data list 22,920 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J9030 — Bcg live intravesical instillation, 1 mg: 13,448 service units.
- J9171 — Injection, docetaxel, 1 mg: 6,688 service units.
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg: 995 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 24 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 208 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 92 prescription fills, including refills.
- Oxybutynin Chloride Er (Oxybutynin Chloride) — 39 prescription fills, including refills.
- Finasteride — 26 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 6 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: 573. Middle half: 187 to 1,871.
More Medicare Part B services than 95% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: 1,869. Middle half: 703 to 4,858.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 18,645 in 2020 to 22,920 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
675 N Saint Clair St
Galter 20-150
Chicago, IL 606115975
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Northwestern Medical Faculty Foundation. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Northwestern University Feinberg Medical School
2005
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
386 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $346,881 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $267,373 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
456 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$8,594 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $55,894.81 across 42 records.
By nature of payment (3 largest of 5)
- Consulting Fee: $39,872.50 across 17 records.
- Education: $9,855.00 across 3 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $4,275.00 across 1 record.
Reporting-company totals (3 largest of 10)
- Janssen Research & Development, LLC: $14,300.00 across 4 records.
- Olympus Corporation of the Americas: $11,174.68 across 18 records.
- UROGEN PHARMA, INC.: $7,507.50 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
21 years (graduated 2005)
CMS Doctors and Clinicians data list 2005 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Meeks has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Meeks as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: 573. Middle half: 187 to 1,871.
More Medicare Part B services than 95% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: 1,869. Middle half: 703 to 4,858.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: $62,507. Middle half: $17,593 to $147,521.
A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $150,002. Middle half: $69,734 to $268,150.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: $47,277. Middle half: $13,074 to $104,973.
A higher Medicare payment amount than 85% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $113,671. Middle half: $51,216 to $199,881.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Urology in Chicago, IL (2024, 97 clinicians with data). Median for this group: 95. Middle half: 44 to 460.
Fewer Part D prescriptions than 70% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: 813. Middle half: 123 to 1,932.
Part D drug cost
Close to the middle for clinicians listed under Urology in Chicago, IL (2024, 97 clinicians with data). Median for this group: $4,095. Middle half: $289 to $55,751.
A lower Part D drug cost than 70% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: $79,867. Middle half: $8,053 to $301,934.
193 active clinicians are listed under Urology with a practice address in Chicago, IL (629 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chicago
29.5% of these 193 clinicians have the CMS telehealth indicator.
40.4% of these 193 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 23% from 18,645 in 2020 to 22,920 in 2024.
- 2020: 18,645
- 2021: 20,213
- 2022: 18,110
- 2023: 20,705
- 2024: 22,920
-
Medicare-allowed amount
Medicare-allowed amount increased 99% from $174,628 in 2020 to $346,881 in 2024.
- 2020: $174,628
- 2021: $273,569
- 2022: $308,412
- 2023: $335,762
- 2024: $346,881
-
Paid by Medicare
Paid by Medicare increased 101% from $132,903 in 2020 to $267,373 in 2024.
- 2020: $132,903
- 2021: $213,388
- 2022: $237,853
- 2023: $259,012
- 2024: $267,373
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 33% from 312 in 2020 to 208 in 2024.
- 2020: 312
- 2021: 269
- 2022: 267
- 2023: 290
- 2024: 208
-
30-day fills
30-day fills decreased 31% from 660 in 2020 to 456 in 2024.
- 2020: 660
- 2021: 569
- 2022: 573
- 2023: 618
- 2024: 456
-
Part D drug cost
Part D drug cost decreased 41% from $14,566 in 2020 to $8,594 in 2024.
- 2020: $14,566
- 2021: $14,314
- 2022: $13,616
- 2023: $17,102
- 2024: $8,594
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 63% from $34,308.13 in 2021 to $55,894.81 in 2025.
- 2021: $34,308.13
- 2022: $16,026.85
- 2023: $39,768.91
- 2024: $43,935.24
- 2025: $55,894.81
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 42 records totaling $55,894.81.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| UROGEN PHARMA, INC. |
Consulting Fee
Cash or cash equivalent
|
— | General | $7,507.50 |
| Janssen Research & Development, LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $6,435.00 |
| Olympus Corporation of the Americas |
Education
Cash or cash equivalent
|
HD CAMERA HEAD | General | $5,110.00 |
| Ferring Pharmaceuticals Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ADSTILADRIN | General | $4,275.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
PADCEV | General | $3,465.00 |
| Janssen Research & Development, LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,396.25 |
| Janssen Research & Development, LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,038.75 |
| Olympus Corporation of the Americas |
Education
Cash or cash equivalent
|
HD CAMERA HEAD | General | $2,920.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
IMFINZI | General | $2,505.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,240.00 |
| Astellas Pharma US Inc |
Consulting Fee
Cash or cash equivalent
|
Padcev | General | $2,100.00 |
| Olympus Corporation of the Americas |
Education
Cash or cash equivalent
|
HD CAMERA HEAD | General | $1,825.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
PADCEV | General | $1,755.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
IMFINZI | General | $1,670.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,600.00 |
| Janssen Research & Development, LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,430.00 |
| Gyrus ACMI, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $730.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
IMFINZI | General | $500.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
— | General | $500.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
IMFINZI | General | $500.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $500.00 |
| Olympus Corporation of the Americas |
Travel and Lodging
In-kind items and services
|
HD CAMERA HEAD | General | $452.97 |
| Olympus Corporation of the Americas |
Travel and Lodging
In-kind items and services
|
HD CAMERA HEAD | General | $177.60 |
| Olympus Corporation of the Americas |
Travel and Lodging
In-kind items and services
|
HD CAMERA HEAD | General | $163.33 |
| Olympus Corporation of the Americas |
Travel and Lodging
In-kind items and services
|
HD CAMERA HEAD | General | $158.48 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J9030
Bcg live intravesical instillation, 1 mg
|
13,448 | 50 | $10.00 | $2.88 |
|
J9171
Injection, docetaxel, 1 mg
|
6,688 | 30 | $10.75 | $0.86 |
|
J9201
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
|
995 | 32 | $37.61 | $3.24 |
|
51720
Instillation of anti-cancer drug into bladder
|
511 | 71 | $677.00 | $91.98 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
303 | 187 | $219.00 | $93.37 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
291 | 184 | $1163.00 | $245.57 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
145 | 118 | $88.00 | $16.89 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
106 | 79 | $175.00 | $93.17 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
78 | 71 | $250.00 | $132.18 |
|
52235
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm
|
66 | 53 | $2045.00 | $291.79 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
50 | 47 | $323.00 | $132.26 |
|
52204
Biopsy of bladder using an endoscope
|
38 | 34 | $943.00 | $112.38 |
|
51999
Other procedure on bladder using an endoscope
|
25 | 25 | $7877.11 | $2200.37 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
24 | 24 | $551.58 | $174.67 |
|
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
|
20 | 15 | $119.00 | $51.37 |
|
55866
Surgical removal of prostate and surrounding lymph nodes using an endoscope
|
19 | 19 | $9212.97 | $633.50 |
|
52234
Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm
|
17 | 16 | $1311.00 | $248.14 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
17 | 16 | $434.00 | $187.01 |
|
52332
Insertion of stent in ureter using an endoscope
|
15 | 11 | $875.73 | $105.65 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
14 | 12 | $230.00 | $11.68 |
|
52224
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm
|
14 | 13 | $2755.00 | $794.29 |
|
52240
Destruction and/or removal of large growth of bladder using an endoscope
|
12 | 11 | $3087.60 | $371.27 |
|
74455
Review by radiologist of urinary bladder and urethra images with contrast and after passing urine
|
12 | 12 | $481.00 | $104.88 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
12 | 12 | $380.67 | $116.63 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 92 | 7,427 | $2,018.97 | 30 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | 2,370 | $715.84 | 13 |
| Finasteride | Finasteride | 26 | 1,620 | $481.50 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 75 | $82.28 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | 1,200 | $332.10 | — |
| Myrbetriq | Mirabegron | 11 | 330 | $4,963.66 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20130223000040
IL
0244495802
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Northwestern Medical Faculty Foundation
251 E Huron St, Chicago, IL 606112908
Northwestern Medical Faculty Foundation
1333 W Belmont Ave, Chicago, IL 606575785
Northwestern Medical Faculty Foundation
1475 E Belvidere Rd, Grayslake, IL 600302012
Northwestern Medical Faculty Foundation
250 E Superior, Chicago, IL 606112914
Phone: 3124723660
Northwestern Medical Faculty Foundation
250 E Superior St, Chicago, IL 606112914
Northwestern Medical Faculty Foundation
0 S036 Church St, Winfield, IL 601901203
Northwestern Medical Faculty Foundation
675 N St Clair, Chicago, IL 606115975
Northwestern Medical Faculty Foundation
675 N Saint Clair St, Chicago, IL 606115975
Northwestern Medical Faculty Foundation
251 E Huron, Chicago, IL 606112908
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Practice Nurse
Physician Assistant - Medical
Physician Assistant
Physician Assistant
Physician Assistant (Certified)
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Career & Practice History
NPI enumerated September 24, 2008.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Chicago
- Dr. Jose Quesada-Olarte, MD
- Dr. Peter Reisz, MD
- Ahmad Hefnawy
- Ashley Ross
- Dr. Mark Wille, MD
- Dr. Samuel Ohlander, MD
Mailing Address
680 N Lake Shore Dr, Suite 1000
Chicago, IL 606114546
Phone: 3126958146